Evidence map›Paper›PMID 37439063›Full record

ArticleJournal of the International AIDS Society2023

Implementation and resource needs for long-acting PrEP in low- and middle-income countries: a scoping review.

Delivette Castor, Craig J Heck, Daniela Quigee, Niharika Vasant Telrandhe, Kiran Kui, Jiaxin Wu, Elizabeth Glickson, Kibret Yohannes, Sergio Torres Rueda, Fiammetta Bozzani and 11 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. From guesstimates to game changers: Introducing objective measurement of blood loss for timely postpartum hemorrhage detection in Nigeria, Zambia, and Kenya.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 3 countries.

Delivette CastorDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-0988-9489
Craig J HeckDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-8138-6640
Daniela QuigeeDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
Niharika Vasant TelrandheDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
Kiran KuiDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
Jiaxin WuDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
Elizabeth GlicksonNew York Medical College, Valhalla, New York, USA.
Kibret YohannesUniversity of Virginia School of Medicine, Charlottesville, Virginia, USA.
Sergio Torres RuedaThe London School of Hygiene and Tropical Medicine, London, UK.
Fiammetta BozzaniThe London School of Hygiene and Tropical Medicine, London, UK.
Kathrine MeyersDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
Jason ZuckerDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
Justine DeaconThe CDC Foundation, Atlanta, Georgia, USA.
Katharine KripkeAvenir Health, Takoma Park, Maryland, USA.ORCID 0000-0001-8228-4577
Magdalena E SobieszczykDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
Fern Terris-PrestholtThe London School of Hygiene and Tropical Medicine, London, UK.
Christine MalatiUnited States Agency for International Development, Washington, DC, USA.ORCID 0000-0002-3174-1077
Chris ObermeyerThe Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Anita DamUnited States Agency for International Development, Washington, DC, USA.
Katie SchwartzFHI360, Durham, North Carolina, USA.
Steven ForsytheAvenir Health, Glastonbury, Connecticut, USA.
Columbia University Irving Medical Center · USColumbia University · USLondon School of Hygiene & Tropical Medicine · GBAvenir Health · USUnited States Agency for International Development · USAaron Diamond AIDS Research Center · USCDC Foundation · USFamily Health International 360 · USGlobal Fund to Fight AIDS, Tuberculosis and Malaria · CHNew York Medical College · USUniversity of Virginia · US

Funding

Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
Columbia Collaborative HIV/AIDS Clinical Trials UnitU01AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HAMMER, SCOTT M · 2007 to 2011
$15.4M
Global HIV Implementation Science Research Training Grant RenewalT32AI114398 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yael R Hirsch-Moverman · 2014 to 2026
$4.1M
Harnessing Bioinformatics for HIV Prevention: Understanding Persistence in Comprehensive HIV Prevention ServicesK23AI150378 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZUCKER, JASON · 2020 to 2024
$960k
NIAID NIH HHS K23 AI150378NIAID NIH HHS T32 AI114398NIAID NIH HHS U01 AI069470NIAID NIH HHS UM1 AI069470PEPFAR
6 · The paper itself

Abstract

introductionSeveral low- and middle-income countries (LMICs) are preparing to introduce long-acting pre-exposure prophylaxis (LAP). Amid multiple pre-exposure prophylaxis (PrEP) options and constrained funding, decision-makers could benefit from systematic implementation planning and aligned costs. We reviewed national costed implementation plans (CIPs) to describe relevant implementation inputs and activities (domains) for informing the costed rollout of LAP. We assessed how primary costing evidence aligned with those domains.

methodsWe conducted a rapid review of CIPs for oral PrEP and family planning (FP) to develop a consensus of implementation domains, and a scoping review across nine electronic databases for publications on PrEP costing in LMICs between January 2010 and June 2022. We extracted cost data and assessed alignment with the implementation domains and the Global Health Costing Consortium principles.

resultsWe identified 15 implementation domains from four national PrEP plans and FP-CIP template; only six were in all sources. We included 66 full-text manuscripts, 10 reported LAP, 13 (20%) were primary cost studies-representing seven countries, and none of the 13 included LAP. The 13 primary cost studies included PrEP commodities (n = 12), human resources (n = 11), indirect costs (n = 11), other commodities (n = 10), demand creation (n = 9) and counselling (n = 9). Few studies costed integration into non-HIV services (n = 5), above site costs (n = 3), supply chains and logistics (n = 3) or policy and planning (n = 2), and none included the costs of target setting, health information system adaptations or implementation research. Cost units and outcomes were variable (e.g. average per person-year). DISCUSSION: LAP planning will require updating HIV prevention policies, technical assistance for logistical and clinical support, expanding beyond HIV platforms, setting PrEP achievement targets overall and disaggregated by method, extensive supply chain and logistics planning and support, as well as updating health information systems to monitor multiple PrEP methods with different visit schedules. The 15 implementation domains were variable in reviewed studies. PrEP primary cost and budget data are necessary for new product introduction and should match implementation plans with financing.

conclusionsAs PrEP services expand to include LAP, decision-makers need a framework, tools and a process to support countries in planning the systematic rollout and costing for LAP.

Indexed as

Developing CountriesHIV InfectionsConsensusDatabases, FactualHealth Care CostsHumanseconomicshealthcare costsimplementation planningLMICslong-acting HIV preventionpre-exposure prophylaxis

Identifiers

PMID37439063
PMCPMC10339010
OpenAlexW4384120635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.